Study tests tiny blood “packages” during breast cancer chemotherapy
Part of Cancer, Skin clinical trials.
This trial studies small particles in the blood (called extracellular vesicles) in people receiving chemotherapy before surgery for breast cancer. It may help doctors learn more about what those particles can tell them during neoadjuvant treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign the study informed consent form
- You are female
- You have been diagnosed with breast cancer and your team recommends neoadjuvant chemotherapy (chemo before surgery)
- Your breast cancer treatment plan is not “upfront surgery first”
- If you are in the control group, you do not have breast cancer and have had a recent normal breast exam or imaging within the last 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny particles released by cells (called extracellular vesicles) in people with breast cancer. It may help researchers better understand breast cancer and how it behaves, which could improve future testing or treatments.
This trial looks at tumor cells in the blood of women with breast cancer to understand them better. It may help doctors learn more about how the disease spreads.
This trial looks at tiny particles called exosomes from your blood and leftover tumor tissue to see if they can predict how well chemotherapy works before surgery. The goal is to find markers that help doctors choose the best treatment for you.
This trial is studying tiny molecules in your blood (called microRNAs) to see if they can predict how well breast cancer responds to chemotherapy given before surgery. If you are starting neoadjuvant chemotherapy, this study may help personalize your treatment.
This study checks whether a blood test that looks for “tumor DNA” (circulating tumor DNA) can help evaluate how well neoadjuvant chemotherapy worked for breast cancer. It may help doctors better understand treatment response after surgery.
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.